Education
About Us
Working with TipRanks
Follow Us
Intellipharmaceutics International Inc. (IPCIQ)
:IPCIQ
IPCIQ Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.15
Previous CloseN/A
Volume3.00K
Average Volume (3M)0.00
Market Cap
$2.43M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)2.22M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Apr 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding35,002,666
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
5.56% Other Institutional Investors
94.44% Public Companies and
Individual Investors
IPCIQ FAQ
What was Intellipharmaceutics International Inc.’s price range in the past 12 months?
Intellipharmaceutics International Inc. lowest stock price was $0.06 and its highest was $0.15 in the past 12 months.
What is Intellipharmaceutics International Inc.’s market cap?
Intellipharmaceutics International Inc.’s market cap is $2.43M.
When is Intellipharmaceutics International Inc.’s upcoming earnings report date?
Intellipharmaceutics International Inc.’s upcoming earnings report date is Apr 21, 2025 which is 69 days ago.
How were Intellipharmaceutics International Inc.’s earnings last quarter?
Currently, no data Available
Is Intellipharmaceutics International Inc. overvalued?
According to Wall Street analysts Intellipharmaceutics International Inc.’s price is currently Overvalued.
Does Intellipharmaceutics International Inc. pay dividends?
Intellipharmaceutics International Inc. does not currently pay dividends.
What is Intellipharmaceutics International Inc.’s EPS estimate?
Intellipharmaceutics International Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intellipharmaceutics International Inc. have?
Intellipharmaceutics International Inc. has 35,002,666 shares outstanding.
What happened to Intellipharmaceutics International Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Intellipharmaceutics International Inc.?
Currently, no hedge funds are holding shares in IPCIQ
Company Description
Intellipharmaceutics International Inc.
Intellipharmaceutics International, Inc. is a pharmaceutical company, which engages in the research, development, and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of existing and new pharmaceuticals in the areas of neurology, cardiovascular, gastrointestinal tract, diabetes and pain. The company was founded by Isa Odidi and Amina Odidi in 1998 and is headquartered in Toronto, Canada.
Technical Analysis
RedHill Biopharma
―
Palatin Technologies
―
Avinger
―
EyePoint Pharmaceuticals
―
PTC Therapeutics
―
Kala Pharmaceuticals
―